Related Experiment Video
Updated: Aug 11, 2026

Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 31, 2010
Primary cardiac amyloidosis with pathologic hip fracture secondary to bone amyloid
A S Sundar1, K K Talwar, P Chopra
1Department of Cardiology, All India Institute of Medical Sciences, New Delhi.
Insights
A rare case of cardiac and bone amyloidosis occurred in a 39-year-old female, presenting with restrictive heart disease and bone lesions. Diagnosis was confirmed via endomyocardial and bone biopsy.
Area of Science:
- Cardiology
- Oncology
- Pathology
Background:
- Amyloidosis is a rare condition characterized by the buildup of abnormal proteins (amyloid) in organs.
- Primary amyloidosis can affect the heart (cardiac amyloidosis) or bone, but concurrent presentation is exceptionally uncommon.
Observation:
- A 39-year-old female presented with symptoms indicative of restrictive heart disease.
- She also exhibited a destructive bone lesion, raising suspicion for systemic involvement.
Findings:
- The patient was diagnosed with a rare co-occurrence of primary cardiac amyloidosis and bone amyloidosis.
- Diagnostic confirmation was achieved through endomyocardial biopsy and bone biopsy, revealing amyloid deposition in both tissues.
Implications:
- This case highlights the importance of considering systemic amyloidosis in patients with unexplained cardiac and bone abnormalities.
- Further research into the pathogenesis and treatment of combined cardiac and bone amyloidosis is warranted.
Abstract:
A rare combination of primary cardiac amyloidosis and bone amyloidosis is described in a 39-year-old female. The presenting features were restrictive heart disease and a destructive bone lesion. The diagnosis was confirmed with the help of endomyocardial and bone biopsy.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Alzheimer Disease ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology

